Table 3.
Deposition of PrPSc in microdissected areas of 87V scrapie model.
| DPI | A | B | C | D | E | F | G | |||||||
| W | I | W | I | W | I | W | I | W | I | W | I | W | I | |
| 30 | ||||||||||||||
| 60 | ||||||||||||||
| 90 | ||||||||||||||
| 120 | ||||||||||||||
| 150 | + | ? | + | |||||||||||
| 180 | + | N/A | + | N/A | N/A | |||||||||
| 210 | + | + | + | + | N/A | |||||||||
| 240 | + | + | + | + | + | + | ? | + | + | + | ? | + | ||
| 270 | + | + | + | + | + | + | + | ? | + | + | + | + | + | |
| 300 | All -ve | + | + | + | + | + | + | + | ? | + | + | + | + | + |
Comparison of dissected brain areas (A-G as in Fig. 2) throughout time course of disease (dpi) in 87V scrapie model. PrPSc deposition (+) visualised by immunocytochemistry (I) and western blotting(W) using 6H4Mab, (?) denotes where PrPSc was visualised in one brain only(see section 2.4), section not available (N/A).